Canada Academy / Professional development
Diabetes Awareness and Support — Canada
Understand diabetes, daily support, monitoring safeguards and emergency recognition. Practical glucose measurement and insulin administration require separate authorized training and assessment.
Learning outcomes
Free · Allow approximately 30 minutes including practice · 13 lessons · 13 questions · 80% to pass
- Explain diabetes mellitus and the role of insulin.
- Distinguish common diabetes types and recognize possible symptoms.
- Interpret dated Canadian diabetes statistics without substituting them for UK epidemiology.
- Describe important complications and why observation and screening matter.
- Describe the main components of individualized diabetes management.
- Explain preparation, accuracy and recording safeguards for capillary glucose testing; practical performance remains separately assessed.
- Explain why blood pressure and cholesterol matter alongside glucose management.
- Identify diabetes team members and coordinate appropriate support.
- Describe monitoring and screening and support an individualized follow-up plan.
- Recognize insulin product, device and administration safeguards without claiming procedural authorization.
- Support independence through individualized diabetes education and assistance.
- Recognize possible hypoglycaemia and distinguish oral treatment from an emergency response.
- Recognize possible diabetic ketoacidosis and obtain urgent assessment without relying on glucose alone.
Original NurseFlex professional learning, published 14 October 2026. Independent education review is pending. This is not an accredited qualification, clinical skills assessment, legal advice, regulator approval or confirmation that an employer accepts the course. English edition; a reviewed French edition is not yet available.
Lessons and practice activities
Glucose regulation and individual care
Diabetes mellitus is a condition in which blood glucose remains elevated because the body does not produce enough insulin, does not use insulin effectively, or both. Insulin is a hormone made by the pancreas that helps regulate glucose use and storage. Diabetes is not defined simply by eating sweet foods, and the diagnosis should not be used as a judgement about a person’s choices or character.
Different types require different treatment, and the plan must reflect the person’s diagnosis, medicines, circumstances and preferences. A support worker follows the authorized plan and reports concerns rather than diagnosing diabetes from appearance or changing treatment in response to one number. Measurements need the correct unit and context; in Canadian care, glucose is commonly recorded in mmol/L, but the actual device and documentation requirements must be checked.
Fictional example: a worker hears “diabetes” at handover and assumes the person must use insulin and avoid every carbohydrate-containing food. Those assumptions do not establish the person’s needs. Check the documented diagnosis, meal and medicine plan, monitoring instructions and escalation contacts. Ask the responsible professional to clarify missing information before assisting with a task requiring it.
Practice: Fictional practice: Rewrite a handover that says only “diabetic diet” into a list of questions requiring clarification; do not invent an individual menu or treatment.
Types and symptoms are not interchangeable
Type 1 diabetes usually involves autoimmune destruction of insulin-producing cells and requires insulin treatment. Type 2 involves insulin resistance and inadequate insulin production; it may be managed with several approaches, including insulin where prescribed. Gestational diabetes is diagnosed during pregnancy and requires pregnancy-specific care and follow-up. Other forms can arise from particular genetic conditions, pancreatic disease or medicines. Age or body size alone cannot establish the type.
Possible symptoms include increased thirst, frequent urination, fatigue, blurred vision and unexplained weight loss. Type 1 symptoms can develop quickly. Type 2 may develop gradually and may produce few or no noticeable symptoms, so absence of symptoms does not exclude it. The same symptom may have other causes; a support worker should report observations and arrange the assessment appropriate to urgency rather than assign a diagnosis.
Fictional example: a person reports new thirst and frequent urination but says they cannot have diabetes because they feel otherwise well. Explain that symptoms are not a reliable exclusion test and support timely clinical advice. If the person appears acutely unwell, follow the urgent-care pathway instead of waiting for a routine appointment. Do not diagnose the type from this short description or recommend a medicine.
Practice: Fictional practice: Compare type 1, type 2 and gestational diabetes, then explain why symptom recognition supports assessment but does not establish the diagnosis.
Canadian population evidence and its limits
Public Health Agency of Canada statistics published in November 2025 report approximately 3.9 million people, or 9.7% of the population aged one year and older, living with diagnosed diabetes in 2023–2024. This is a dated population estimate, not the proportion of residents expected in every care setting. The figure combines diabetes types but excludes gestational diabetes, undiagnosed diabetes and prediabetes. Those exclusions matter when describing what the number represents.
Prevalence describes how many people have a condition within a defined population and period; incidence describes new cases. Neither tells a worker which particular resident has diabetes or how their care should be arranged. Different age ranges, diagnostic definitions and years can produce different estimates. A statistic from a different population should not be presented as a contradiction until its definition has been checked.
Fictional practice example: a presentation labels the national figure “all Canadians with any form of diabetes today.” Correct it by naming the age group, reference year and diagnosed-diabetes scope. A facility may serve an older or otherwise different population, so its own service planning requires local evidence. This Canadian lesson does not satisfy the benchmark’s literal requirement to discuss UK epidemiology; that mapping remains excluded.
Practice: Rewrite the fictional presentation label with the year, population and exclusions, then explain why it cannot estimate an individual resident’s risk.
Feet, kidneys, nerves and eyes
Diabetes can affect blood vessels and nerves. Neuropathy may cause pain, tingling or reduced sensation; reduced sensation can allow a foot injury to go unnoticed. Impaired circulation and injury can contribute to ulcers and infection. Kidney disease and diabetic retinopathy, which affects the retina, may develop without obvious early symptoms. Regular professional checks are therefore important even when the person reports feeling well.
Support the agreed foot-care, screening and follow-up plan. Report a new wound, swelling, warmth, colour change, pain or other concern promptly through the appropriate clinical route. Do not assume that a painless foot wound is minor, and do not attempt unfamiliar nail cutting, corn removal or wound treatment. Help the person access appointments and communicate barriers such as difficulty travelling or understanding instructions.
Fictional example: a person cannot see the sole of their foot and has not noticed a new skin break. A worker assisting under the plan observes the change and obtains clinical advice, while recording what was actually seen. The absence of pain does not remove the concern. The worker does not diagnose infection or choose a dressing independently. The role is to identify and communicate a possible problem and support the authorized response.
Practice: Fictional practice: Explain why both a painless foot wound and routine eye screening deserve attention; distinguish your observations from a clinical diagnosis.
A coordinated daily plan
Diabetes management combines several approaches chosen for the person’s type of diabetes and circumstances. These include nutrition, appropriate physical activity, glucose monitoring, prescribed medicines and support for emotional wellbeing. Some people use tablets, some use injectable medicines, and some use insulin. Insulin treatment is essential in type 1 diabetes; a healthier diet does not replace it. In type 2 diabetes, needing medicine or insulin is not evidence of personal failure.
A worker should understand the daily plan before providing support: meal arrangements, activity preferences, monitoring times, medication responsibilities and escalation contacts. Changes in eating, illness or activity may affect management. Report these changes to the responsible professional rather than independently changing a medicine or introducing a restrictive diet. A registered dietitian can help develop an eating plan that fits nutritional needs, preferences, culture and available food.
Fictional example: a resident has eaten little lunch and asks to attend an unusually long exercise session. The worker checks the authorized plan and communicates the changed intake and proposed activity to the responsible clinician, particularly where medicine-related low glucose is a concern. The worker helps find a safe, agreed activity rather than automatically forbidding participation or guessing a dose adjustment. Document the advice and what actually happened.
Practice: Fictional practice: List the information needed before supporting the proposed activity, and identify which decisions require the clinician’s input.
A reliable reading needs a reliable process
Before assisting with a glucose test, confirm the person, consent, authorized task, monitoring plan and device-specific training. Health Canada advises following the meter and strip instructions, using compatible supplies and checking expiry. Wash and thoroughly dry hands: food residue may distort a result and water may dilute the sample. Use a fresh sterile lancet and never share a lancing device. Follow the approved infection-prevention, sharps-disposal and equipment-cleaning procedures for the care setting.
A meter result is not automatically reliable because a number appears. Incorrect sample volume, unsuitable strips, storage conditions and some clinical factors can affect accuracy. Follow the manufacturer’s control-testing instructions and the care plan for unexpected results. Report a result that conflicts with the person’s symptoms and obtain prompt clinical direction. Do not delay an emergency response while repeatedly troubleshooting equipment. A symptomatic person needs assessment, not reassurance based only on a device display.
Record the actual result and unit, date and time, relevant meal or symptom context, action taken and whom you informed in the authorized record. Never invent a result when testing fails. Fictional example: after handling fruit, a resident receives an unexpected reading. The worker reports the concern and follows the approved repeat-testing process with clean, dry hands while assessing urgency. They retain an accurate account of the original result and follow-up rather than silently replacing it. This lesson and quiz do not demonstrate safe practical performance on a real device.
Practice: Fictional practice: Write a record for an unexpected reading with the value left as a placeholder; include circumstances, escalation and follow-up without inventing observations.
Protecting cardiovascular health
Diabetes care addresses more than glucose. Blood pressure and blood lipids contribute to cardiovascular risk, so a glucose reading within the person’s target range does not establish that all risks are controlled. Diabetes Canada recommends working with the care team on blood pressure, cholesterol, activity, nutrition and other risk factors. Prescribed medicines may have a protective purpose even when the person feels well; the worker should not infer that a medicine is unnecessary from the absence of symptoms.
Use the person’s documented targets and monitoring schedule. Do not substitute a general educational target for an individualized instruction, and do not increase or omit a dose to correct a single reading. When authorized to take a blood pressure, use the approved technique and equipment and record the value, time and relevant circumstances. Report readings or symptoms through the person’s escalation plan; urgent symptoms require urgent assessment rather than waiting for the next routine review.
Fictional example: a resident says their glucose has improved and asks whether they can stop their cholesterol medicine. A helpful response explains that glucose and cardiovascular protection are separate parts of the plan, then supports a conversation with the prescriber or pharmacist. Record the question and any reported side effects accurately. A support worker should neither dismiss the concern nor approve a medication change.
Practice: Prepare a short explanation for the fictional resident and identify which professional should clarify the medicine’s purpose and any side effects.
Working with the person and their care team
The person living with diabetes is central to the care team. Depending on need and local resources, professionals may include a primary care provider, diabetes specialist, nurse educator, dietitian, pharmacist, eye-care or foot-care specialist, social worker and mental-health professional. The team’s combined contribution addresses treatment, learning, nutrition, medicines, complications and barriers to daily care. Not every person needs every specialist, and a list of names does not by itself establish a coordinated plan.
Know who coordinates care, how to contact them and what information they need. For a medication concern, the pharmacist or prescriber can clarify the regimen; a nutrition concern may need a dietitian; financial or access difficulties may need a social worker or service coordinator. Urgent deterioration must use the emergency pathway rather than wait for a routine specialist referral. Share relevant information through authorized channels, respecting the person’s consent and privacy.
Fictional example: a resident repeatedly misses appointments because transport is unavailable. Simply sending another appointment reminder leaves the barrier unresolved. Ask what support they want, tell the designated coordinator the specific difficulty, and agree who will arrange transport and confirm the appointment. At handover, distinguish a referral sent from advice received or an appointment attended. Close the loop so the next worker can see what remains to be done.
Practice: Fictional practice: Allocate a medication question, meal-planning difficulty and transport problem to appropriate team contacts; write a handover showing unresolved actions.
Follow-up beyond a single glucose reading
Monitoring includes reviewing glucose records and longer-term measures such as A1C, while complication screening looks for problems that may not yet cause symptoms. Diabetes Canada’s patient checklist includes blood pressure review, cholesterol testing, kidney checks such as urine albumin-to-creatinine ratio, foot assessment and professional eye examination. These checks answer different questions. A reassuring home glucose reading does not replace an eye examination or a kidney test.
The timing of tests depends on diabetes type, duration, age, pregnancy, existing findings and the treating team’s decisions. Use the current individualized schedule rather than applying one interval to everyone. Help the person identify which appointment or test is due, obtain accessible instructions and arrange practical support with consent. New symptoms or a new foot wound need appropriate timely assessment; a future screening appointment is not a reason to delay reporting a current problem.
Fictional example: a resident’s calendar shows an eye appointment but transport has not been booked. They say the visit is unnecessary because their meter reading was satisfactory. Explain that the tests assess different aspects of health, help resolve the transport issue and notify the relevant coordinator if access remains uncertain. Document the barrier and who will follow it up. Do not record the examination as completed simply because an appointment exists.
Practice: Create a fictional follow-up checklist with separate columns for test, due date, access barrier, responsible person and confirmed completion. Do not invent clinical intervals.
Insulin safety and the limits of this lesson
Insulin errors can cause serious harm. Before any authorized assistance or administration, the trained professional must reconcile the person, current order, exact insulin product and concentration, dose expressed in units, delivery device, timing and relevant monitoring instructions. Similar names or packaging do not establish interchangeability. ISMP Canada describes harm when a dose was communicated using syringe markings rather than the actual insulin units. Unclear instructions or a changed product require clarification with the prescriber or pharmacist before proceeding.
Insulin pens are for one person only, even if the needle is changed. Follow product-specific storage, expiry and device instructions; do not assume every insulin has the same storage period after opening. Training must cover the actual device, preparation, priming where applicable, dose selection, injection sites and rotation, sharps disposal, monitoring and the response to low glucose. Diabetes Canada’s pen-start checklist includes return demonstration. Reading a summary does not replace supervised teaching or the authority required for the task.
Fictional example: a delivery contains a different concentration from the product listed on the record, and a colleague suggests using the same number of clicks. Stop that proposed administration and obtain urgent clarification from the responsible clinician or pharmacist so necessary treatment is not simply omitted without a plan. Do not calculate a conversion or borrow another resident’s pen. Record the discrepancy and the instructions received. This unit teaches recognition and escalation; complete device-specific administration, local authorization and observed competence remain outstanding.
Practice: Fictional practice: List the product, concentration, units, device and order details needed to resolve the discrepancy. Explain why changing a needle does not make sharing a pen safe.
Enable participation without taking over
Independence means supporting the person’s informed participation, including asking for help when needed. Diabetes education should fit their treatment, learning needs, language, culture, preferences and circumstances. A person may confidently manage one task but need assistance with another. Avoid assuming that age, diagnosis or difficulty reading a label establishes inability to participate. Ask what they normally do, what matters to them and what support would make the task manageable.
Use accessible explanations and the approved learning materials, then invite the person to describe the agreed next step in their own words. This checks how clearly the information was explained rather than testing or blaming them. Practical tasks require teaching and assessment by an appropriately qualified professional. Support workers should not use this course or an AI-generated instruction as authority to change an insulin regimen or certify someone’s clinical competence.
Fictional example: a resident understands their monitoring schedule but cannot read the small print on a new device. Taking over every aspect of their diabetes care would remove abilities they still have. With their agreement, arrange appropriate device education and accessible materials, and clarify what assistance is needed meanwhile. Record the agreed support and review it when circumstances change. The resident’s own priorities should remain visible in the plan.
Practice: Fictional practice: Write an accessible explanation and a respectful teach-back question for the device scenario. Identify the professional assessment needed before unsupervised device use.
Low glucose: swallowing safety comes first
Low glucose can cause sweating, trembling, hunger, weakness, confusion or altered behaviour; some people have little warning. Check glucose promptly when possible and follow the person’s low-glucose plan. For an adult who is alert and can swallow safely, Diabetes Canada guidance describes 15 grams of fast-acting carbohydrate for level 1 or 2 hypoglycaemia, followed by a glucose recheck after 15 minutes and repeat treatment if still below 4 mmol/L. Use the labelled amount of glucose tablets or another approved fast-acting source; do not guess the carbohydrate content.
This general adult approach does not replace an individualized plan, especially for children, automated insulin-delivery users or severe episodes. If the person is unconscious, having a seizure or cannot swallow safely, give nothing by mouth and activate emergency help immediately. Call 911 or the facility emergency response. An appropriately trained and authorized person should give prescribed glucagon according to its product instructions and the emergency plan. Do not wait for oral treatment to work when it cannot be given safely.
Stay with the person and follow dispatcher or emergency-team instructions. If they are unresponsive and not breathing normally, begin CPR and use an AED according to your training and emergency instructions. Once recovered, follow the plan for further monitoring and food, and arrange clinical review of the episode. Fictional example: a confused resident cannot safely drink juice. The worker calls for emergency assistance instead of forcing a drink, communicates the glucose result if available and prepares the medication record for responders. Record symptoms, times, treatment and response accurately.
Practice: Fictional practice: Contrast an alert adult who can swallow with a resident who cannot. Explain when the oral-treatment route must stop and who supplies emergency help.
DKA is an emergency, not a routine high reading
Diabetic ketoacidosis, or DKA, is a serious metabolic emergency involving ketone accumulation and acidosis. Warning features can include increased thirst and urination, weakness, nausea, vomiting, abdominal pain, abnormal deep or difficult breathing and altered alertness. A person may be very unwell. Diabetes Canada cautions that normal or only mildly elevated glucose does not rule out DKA, particularly with SGLT2 inhibitor use or pregnancy. Do not require a very high meter reading before taking these symptoms seriously.
Suspected DKA needs urgent medical assessment. Call 911 or activate the facility emergency response for impaired consciousness, breathing difficulty or severe deterioration. Follow the individualized sick-day plan for contacting the clinical team and checking ketones when trained and equipped, but do not delay emergency help while finding a test kit. Treatment requires professional monitoring and is not a task to improvise with extra insulin, exercise or forced drinks. Do not change or omit medicines independently; obtain urgent clinical direction.
Fictional example: a resident taking an SGLT2 inhibitor is vomiting, has abdominal pain and becomes drowsy, although glucose is not markedly elevated. The worker activates emergency help and reports the symptoms, medication, timing and any available readings. Saying “the sugar is not high enough for DKA” would create a dangerous delay. After transfer, the team should review the sick-day plan and access to supplies. A quiz establishes recognition knowledge only; it does not qualify someone to diagnose DKA or administer hospital treatment.
Practice: Fictional practice: Give an emergency handover for the scenario using only known observations; include the medicine and explain why the glucose result does not exclude DKA.
Reference resources for Canadian learners
These resources support further study. Their inclusion does not imply endorsement or accreditation of NurseFlex.
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Health Canada / PHAC
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Health Canada / PHAC
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Health Canada / PHAC
- Health Canada / PHAC
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Canada: reference guidance
- Diabetes Québec
- Alberta health information
- Diabetes Canada: reference guidance
- Alberta health information